Literature DB >> 30520687

Oxidative stress and macrophages: driving forces behind exacerbations of asthma and chronic obstructive pulmonary disease?

Linsey E S de Groot1,2, T Anienke van der Veen3,4, Fernando O Martinez5, Jörg Hamann2, René Lutter1,2, Barbro N Melgert3,4.   

Abstract

Oxidative stress is a common feature of obstructive airway diseases like asthma and chronic obstructive pulmonary disease (COPD). Lung macrophages are key innate immune cells that can generate oxidants and are known to display aberrant polarization patterns and defective phagocytic responses in these diseases. Whether these characteristics are linked in one way or another and whether they contribute to the onset and severity of exacerbations in asthma and COPD remain poorly understood. Insight into oxidative stress, macrophages, and their interactions may be important in fully understanding acute worsening of lung disease. This review therefore highlights the current state of the art regarding the role of oxidative stress and macrophages in exacerbations of asthma and COPD. It shows that oxidative stress can attenuate macrophage function, which may result in impaired responses toward exacerbating triggers and may contribute to exaggerated inflammation in the airways.

Entities:  

Keywords:  macrophage polarization; obstructive lung disease; oxidant and antioxidant

Mesh:

Year:  2018        PMID: 30520687     DOI: 10.1152/ajplung.00456.2018

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  16 in total

Review 1.  Resolution of allergic asthma.

Authors:  Susetta Finotto
Journal:  Semin Immunopathol       Date:  2019-11-08       Impact factor: 9.623

Review 2.  Recent evidence from omic analysis for redox signalling and mitochondrial oxidative stress in COPD.

Authors:  Sharon Mumby; Ian M Adcock
Journal:  J Inflamm (Lond)       Date:  2022-07-11       Impact factor: 6.283

3.  Regulation of Lung Macrophage Activation and Oxidative Stress Following Ozone Exposure by Farnesoid X Receptor.

Authors:  Mary Francis; Grace Guo; Bo Kong; Elena V Abramova; Jessica A Cervelli; Andrew J Gow; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Sci       Date:  2020-10-01       Impact factor: 4.849

Review 4.  Oxidative Stress Biomarkers in Chronic Obstructive Pulmonary Disease Exacerbations: A Systematic Review.

Authors:  Elisabetta Zinellu; Angelo Zinellu; Alessandro G Fois; Maria Carmina Pau; Valentina Scano; Barbara Piras; Ciriaco Carru; Pietro Pirina
Journal:  Antioxidants (Basel)       Date:  2021-04-29

5.  Asthma without borders.

Authors:  Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-04-01       Impact factor: 6.011

6.  Protective Effects of Licochalcone A Improve Airway Hyper-Responsiveness and Oxidative Stress in a Mouse Model of Asthma.

Authors:  Wen-Chung Huang; Chien-Yu Liu; Szu-Chuan Shen; Li-Chen Chen; Kuo-Wei Yeh; Shih-Hai Liu; Chian-Jiun Liou
Journal:  Cells       Date:  2019-06-20       Impact factor: 6.600

7.  Serum heme oxygenase-1 measurement is useful for evaluating disease activity and outcomes in patients with acute respiratory distress syndrome and acute exacerbation of interstitial lung disease.

Authors:  Ryo Nagasawa; Yu Hara; Kota Murohashi; Ayako Aoki; Nobuaki Kobayashi; Shigeto Takagi; Satoru Hashimoto; Akihiko Kawana; Takeshi Kaneko
Journal:  BMC Pulm Med       Date:  2020-11-25       Impact factor: 3.317

8.  Sesamol Alleviates Airway Hyperresponsiveness and Oxidative Stress in Asthmatic Mice.

Authors:  Chian-Jiun Liou; Ya-Ling Chen; Ming-Chin Yu; Kuo-Wei Yeh; Szu-Chuan Shen; Wen-Chung Huang
Journal:  Antioxidants (Basel)       Date:  2020-04-01

9.  High-dose N-acetylcysteine for long-term, regular treatment of early-stage chronic obstructive pulmonary disease (GOLD I-II): study protocol for a multicenter, double-blinded, parallel-group, randomized controlled trial in China.

Authors:  Heshen Tian; Yumin Zhou; Longhui Tang; Fan Wu; Zhishan Deng; Bijia Lin; Peiyu Huang; Shaodan Wei; Dongxing Zhao; Jingping Zheng; Nanshan Zhong; Pixin Ran
Journal:  Trials       Date:  2020-09-11       Impact factor: 2.279

10.  Activation of angiotensin II type-2 receptor protects against cigarette smoke-induced COPD.

Authors:  Dan Mei; W S Daniel Tan; Wupeng Liao; C K Matthew Heng; W S Fred Wong
Journal:  Pharmacol Res       Date:  2020-10-02       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.